Dimensional Fund Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,253
| Closed | -$255K | – | 3520 |
|
|
2022
Q2 | $255K | Sell |
20,253
-6,986
| -26% | -$88K | ﹤0.01% | 3215 |
|
|
2022
Q1 | $1.57M | Sell |
27,239
-384
| -1% | -$22.1K | ﹤0.01% | 2886 |
|
|
2021
Q4 | $3.28M | Buy |
27,623
+2,310
| +9% | +$274K | ﹤0.01% | 2702 |
|
|
2021
Q3 | $5.03M | Buy |
25,313
+1,149
| +5% | +$228K | ﹤0.01% | 2582 |
|
|
2021
Q2 | $4.21M | Buy |
24,164
+427
| +2% | +$74.3K | ﹤0.01% | 2661 |
|
|
2021
Q1 | $4.69M | Buy |
23,737
+2,135
| +10% | +$422K | ﹤0.01% | 2604 |
|
|
2020
Q4 | $4.25M | Buy |
21,602
+1,624
| +8% | +$320K | ﹤0.01% | 2578 |
|
|
2020
Q3 | $3.54M | Buy |
19,978
+29
| +0.1% | +$5.14K | ﹤0.01% | 2569 |
|
|
2020
Q2 | $4.61M | Sell |
19,949
-1,164
| -6% | -$269K | ﹤0.01% | 2501 |
|
|
2020
Q1 | $2.46M | Sell |
21,113
-113
| -0.5% | -$13.2K | ﹤0.01% | 2646 |
|
|
2019
Q4 | $4.05M | Sell |
21,226
-212
| -1% | -$40.5K | ﹤0.01% | 2682 |
|
|
2019
Q3 | $4.12M | Buy |
21,438
+654
| +3% | +$126K | ﹤0.01% | 2666 |
|
|
2019
Q2 | $3.56M | Buy |
20,784
+2,760
| +15% | +$473K | ﹤0.01% | 2747 |
|
|
2019
Q1 | $3.63M | Buy |
18,024
+6,575
| +57% | +$1.32M | ﹤0.01% | 2745 |
|
|
2018
Q4 | $2.14M | Buy |
11,449
+4,796
| +72% | +$898K | ﹤0.01% | 2854 |
|
|
2018
Q3 | $1.59M | Buy |
6,653
+2,979
| +81% | +$713K | ﹤0.01% | 2974 |
|
|
2018
Q2 | $972K | Hold |
3,674
| – | – | ﹤0.01% | 3032 |
|
|
2018
Q1 | $911K | Buy |
3,674
+2,227
| +154% | +$552K | ﹤0.01% | 3017 |
|
|
2017
Q4 | $196K | Buy |
1,447
+907
| +168% | +$123K | ﹤0.01% | 3225 |
|
|
2017
Q3 | $64K | Buy |
+540
| New | +$64K | ﹤0.01% | 3297 |
|